Table 3.

Score values of muscle strength tools in the 3 patient datasets.

NMean (SD)Min–MaxMedian (1st–3rd Quartile)Median Value/Maximum Score (%)
Routine dataset
    MMT-4 (0–40)11532.6 (7.7)10–4036 (28–39)90
    MMT-6 (0–60)11550.6 (10.2)20–6054 (44–59)90
    MMT-8 (0–80)11568.8 (12.6)26–8073 (61–79)91.3
    CMAS (0–52)9341.3 (12.2)5–5247 (34–52)90.4
    hMC (0–100)10282.3 (18.6)26–10089 (68–98)89
JDM trial dataset
    MMT-4 (0–40)13718.6 (8.9)0–3819 (12–25)47.5
    MMT-6 (0–60)13630.6 (13.3)0–5832 (22–40)53.3
    MMT-8 (0–80)13644 (17.6)2–7846 (33.5–57)57.5
    CMAS (0–52)13922.1 (12.6)0–5120 (13–33)38.5
    hMC (0–100)13848.2 (20.9)0–9749 (34–63)49
Outcome dataset
    MMT-4 (0–40)32237.4 (5.5)6–4040 (37–40)100
    MMT-6 (0–60)32256.6 (7.5)10–6060 (57–60)100
    MMT-8 (0–80)32276 (9.3)15–8080 (77–80)100
    CMAS (0–52)32247.5 (9)1–5251 (47–52)98.1
    hMC (0–100)32293.2 (13.2)15–10099 (93–100)99
  • CMAS: Childhood Myositis Assessment Scale; hMC: hybrid MMT-8/CMAS; JDM: juvenile dermatomyositis; MMT: Manual Muscle Test.